As a prognostic marker, different studies demonstrated that IMP3 can identify subgroups of patients affected by localized renal cell carcinomas, superficial urothelial carcinomas, and colorectal carcinomas with poorer prognosis [22]. Here, IMP3 is linked to colorectal carcinoma.